bfpet
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2008 (NCT00733460)
Timeline
Indications
Studied for
Mechanism of action
- Unspecified targetOTHER
Diagnostic
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
Loading structure…
SMILES
Fc1ccc([P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1- Mol. weight
- 357.39 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2221306 ↗
Also known as
- bfpet
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02252783 | Phase 2 | May 1, 2017 | FluoroPharma, Inc., Harvard University |
| NCT00733460 | Phase 1 | Mar 1, 2008 | FluoroPharma, Inc., Harvard University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| FluoroPharma, Inc. | For profit | 2 | 2 | 2 | 2008 |
| Harvard University | Academic/Hospital | 2 | 0 | 2 | 2008 |
2 organizations
Page 1 / 1